These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 32215548)

  • 1. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
    Monteleone G; Ardizzone S
    J Crohns Colitis; 2020 Sep; 14(9):1334-1336. PubMed ID: 32215548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization.
    D'Amico F; Danese S; Peyrin-Biroulet L;
    Gastroenterology; 2020 Jul; 159(1):14-19.e3. PubMed ID: 32360567
    [No Abstract]   [Full Text] [Related]  

  • 3. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.
    Rubin DT; Abreu MT; Rai V; Siegel CA;
    Gastroenterology; 2020 Jul; 159(1):6-13.e6. PubMed ID: 32272113
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
    Marín-Jiménez I; Zabana Y; Rodríguez-Lago I; Marín L; Barreiro-de Acosta M; Esteve M;
    Gastroenterol Hepatol; 2020; 43(7):408-413. PubMed ID: 32419715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor
    Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J
    Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    Siegel CA; Christensen B; Kornbluth A; Rosh JR; Kappelman MD; Ungaro RC; Johnson DF; Chapman S; Wohl DA; Mantzaris GJ
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S769-S773. PubMed ID: 33085972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.
    D'Amico F; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2689-2700. PubMed ID: 32777550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and immunomodulation in IBD.
    Neurath MF
    Gut; 2020 Jul; 69(7):1335-1342. PubMed ID: 32303609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignaß A; Kucharzik T;
    Z Gastroenterol; 2020 Jul; 58(7):672-692. PubMed ID: 32659830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    Reinisch W; Danese S; Peyrin-Biroulet L; Loftus EV
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S815-S819. PubMed ID: 32520311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S
    J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Navaneethan U; Lourdusamy D; LehnerNoguera V; Shen B
    Inflamm Bowel Dis; 2020 Sep; 26(10):e118-e119. PubMed ID: 32676646
    [No Abstract]   [Full Text] [Related]  

  • 17. The Greek Response to COVID-19: A True Success Story from an IBD Perspective.
    Bamias G; Lagou S; Gizis M; Karampekos G; Kyriakoulis KG; Pontas C; Mantzaris GJ
    Inflamm Bowel Dis; 2020 Jul; 26(8):1144-1148. PubMed ID: 32476001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.
    Soo RJJ; Chiew CJ; Ma S; Pung R; Lee V
    Emerg Infect Dis; 2020 Aug; 26(8):1933-1935. PubMed ID: 32339092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.